2050 Capital
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- Switzerland
- Germany
- United Kingdom
Investment stages
- Pre-Seed
- Seed
Industries
- Fintech
- AI
- Health Tech
- Blockchain
- Crypto
About
2050 Capital is an early stage venture Capital firm specializing in deep tech and scientific investments. The firm applies a disciplined and surgical investment approach, backed by indepth due diligence. 2050 Capital typically invests $200500k in seed rounds and up to $3 M in follow on investments, with a track record of over 50% in follow on investments. The firm supports its portfolio companies with business development, strategy, and nextstage fundraising from the initial investment onward. Notable investments include companies such as AMFG, Blackrock Neurotech, ChAI, Hadean, KETS, Origin Sciences, Snyk, Vaticle, and OSCP.
2050 Capital is an early stage venture Capital firm specializing in deep tech and scientific investments. The firm applies a disciplined and surgical investment approach, backed by indepth due diligence. 2050 Capital typically invests $200500k in seed rounds and up to $3 M in follow on investments, with a track record of over 50% in follow on investments. The firm supports its portfolio companies with business development, strategy, and nextstage fundraising from the initial investment onward. Notable investments include companies such as AMFG, Blackrock Neurotech, ChAI, Hadean, KETS, Origin Sciences, Snyk, Vaticle, and OSCP.
Investment Thesis
2050 Capital invests in transformative and defensible innovation that impacts large fundamental sectors, focusing on enterprise software (with a deep science component), computational biotech, and engineering and science ventures.
Portfolio
AMFG
Blackrock Neurotech
ChAI
Hadean
KETS
Origin Sciences
Snyk
Vaticle
OSCP